Immunolocalization of vascular endothelial growth factor in the GH3 cell line

Cell and Tissue Research

Volumn 300, Issue 1, 2000, Pages 83-88

  Vidal, Sergio ^a   Oliveira, M Cristina ^b   Kovacs, Kalman ^c   Scheithauer, Bernd W ^d   Lloyd, Ricardo ^d  

^a Laboratory of Histology   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d MAYO CLINIC   (United States)

Author keywords

GH3 cell line; Immunocytochemistry; Pituitary; Prolactin; Rat; VEGF

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL STRAIN GH3; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM VESICLE; ENDOCRINE FUNCTION; GOLGI COMPLEX; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; ROUGH ENDOPLASMIC RETICULUM; SECRETORY GRANULE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; GROWTH HORMONE; LYMPHOKINES; MICROSCOPY, IMMUNOELECTRON; PARACRINE COMMUNICATION; PITUITARY GLAND; PROLACTIN; RATS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0034034261     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004410050049     Document Type: Article

References (32)

1. Achen MG, Stacker SA (1998) The vascular endothelial growth factor family: proteins which guide the development of the vasculature. Int J Exp Pathol 79:255-265
2. Banerjee SK, Sarkar DK, Weston AP, De A, Campbell DR (1997) Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Carcinogenesis 18:1155-1161
3. Elias KA, Weiner RI (1987) Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fischer 344 rats. Endocrinology 120:617-621
4. Felix R, Meza U, Cota G (1995) Induction of classical lactotropes by epidermal growth factor in rat pituitary cell cultures. Endocrinology 136:939-946
5. Ferrara N (1999) Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 237:1-30
6. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25
7. Ferrara N, Houck K, Jakeman L, Leung DW (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32
8. Finley EL, Ramsdell JS (1994) A transforming growth factor-alpha pathway is expressed in GH4C1 rat pituitary tumors and appears necessary for tumor formation. Endocrinology 135: 416-422
9. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580
10. Jabbour HN, Boddy SC, Lincoln GA (1997) Pattern and localisation of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: expression is independent of hypothalamic control. Mol Cell Endocrinol 134: 91-100
11. Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N (1992) Binding sites for vascular endothelial growth are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244-253
12. Jin L, Chandler WF, Lloyd RV (1994) Localization of basic fibroblast growth factor (bFGF) protein and mRNA in human pituitaries regulation of bFGF mRNA by gonadotropin-releasing hormone. Endocr Pathol 5:27-34
13. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW (1995) Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphologic study. Endocr Pathol 6:115-124
14. Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L (1999) Vascular endothelial growth factor (VEGF) expression in human pituitary adenoma and carcinoma. Endocr Pathol 10:229-235
15. Mallo F, Wilson E, Whorwood CB, Singh S, Sheppard MC (1995) Basic and acidic fibroblast growth factor increase prolactin mRNA in a dose-dependent and specific manner in GH3 cells. Mol Cell Endocrinol 114:117-125
16. Marin F, Boya J (1995) Immunocytochemical localization of basic fibroblast growth factor in the human pituitary gland. Neuroendocrinology 62:523-529
17. Pepper MS, Ferrara N, Orci L, Montesano R (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824-831.
18. Presta M, Foiani M, Rusnati M, Joseph-Silverstein J, Maier JA, Ragnotti G (1988) High molecular weight immunoreactive basic fibroblast growth factor-like proteins in rat pituitary and brain. Neurosci Lett 90:308-313
19. Qian X, Jin L, Grande JP, Lloyd RV (1996) Transforming growth factor-beta and p27 expression in pituitary cells. Endocrinology 137:3051-3060
20. Roth J (1983) The colloidal gold marker system for light and electron microscopic cytochemistry. In: Bullak GR, Petrusz P (eds) Techniques in immunocytochemistry. Academic, New York
21. Scammell JG, Burrage TG, Dannies PS (1986) Hormonal induction of secretory granules in a pituitary tumor cell line. Endocrinology 119:1543-1548
22. Schechter JE, Pattison A, Pattison T (1993) Development of the vasculature of the anterior pituitary: ontogeny of basic fibroblast growth factor. Dev Dyn 197:81-93
23. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P (1998) Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659-1673
24. Senger DR, Connolly DT, Van dW, Feder J, Dvorak HF (1990) Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50:1774-1778
25. Takechi A, Uozumi T, Kawamoto K, Ito A, Kurisu K, Sudo K (1994) Inhibitory effect of TNP-470, a new anti-angiogenic agent, on the estrogen induced rat pituitary tumors. Anticancer Res 14:157-162
26. Tashjian AHJ, Yasumura Y, Levine L, Sato GH, Parker ML (1968) Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82:342-352
27. Tougard C, Picart R, Tixier-Vidal A (1982) Immunocytochemical localization of prolactin in the endoplasmic reticulum of GH3 cells: variations in response to thyroliberin. Biol Cell 43: 89-102
28. Vidal S, Kovacs K, Cohen SM, Stefaneanu L, Lloyd RV, Scheithauer BW (1999) Immunolocalization of vascular endothelial growth factor (VEGF) in nontumorous human pituitaries. Endocr Pathol 10:109-122
29. Wada S, Kaji H, Yoshimura K, Chihara K (1997) Characterization of GH3 cells overexpressing basic fibroblast growth factor (FGF-2). J Neuroendocrinol 9:423-430
30. Yeo TK, Senger DR, Dvorak HF, Freter L, Yeo KT (1991) Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochem Biophys Res Commun 179:1568-1575
31. Ying C, Zhang Z, Huang G, Li SQ, Ying SY (1996) Expression and localization of inhibin/activin and activin receptors in GH3 cells, a rat pituitary adenocarcinoma cell line. J Endocrinol Invest 19:6-11
32. Zachary I (1998) Vascular endothelial growth factor. Int J Biochem Cell Biol 30:1169-1174